3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Head & Neck
1
Breast
1
Conditions
Breast Neoplasms
3865
Motor Activity
228
Neoplasms
202
Prostatic Neoplasms
167
Colorectal Neoplasms
146
Lung Neoplasms
139
Lymphedema
125
Fatigue
104
Ovarian Neoplasms
98
Carcinoma, Intraductal, Noninfiltrating
94
Colonic Neoplasms
86
Breast Cancer Lymphedema
86
Pain
81
Breast Cancer Female
76
Anxiety Disorders
76
Uterine Cervical Neoplasms
73
Depression
70
Triple Negative Breast Neoplasms
66
Breast Carcinoma In Situ
66
Head and Neck Neoplasms
55
Pain, Postoperative
54
Obesity
54
Neoplasm Metastasis
48
Melanoma
42
Endometrial Neoplasms
39
Pancreatic Neoplasms
38
Lymphoma
38
Carcinoma, Non-Small-Cell Lung
34
Sleep Initiation and Maintenance Disorders
33
Sarcoma
33
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Substance-Related Disorders
×
Breast
×
Clear all
NCT03371732
2022-12-02
ONKODETOX
Institut Bergonié
Phase NA
Completed
104 enrolled
48 charts